Skip to content

EFFICACY OF JANU PICHU, BRIMHANA SNEHAPANA AND MATRA BASTI WITH KSHEERABALA TAILA IN THE MANAGEMENT OF SANDHIGAT VATA (OSTEOARTHRITIS ); A COMPARATIVE CLINICAL STUDY

EFFICACY OF JANU PICHU, BRIMHANA SNEHAPANA AND MATRA BASTI WITH KSHEERABALA TAILA IN THE MANAGEMENT OF SANDHIGAT VATA (OSTEOARTHRITIS ); A COMPARATIVE CLINICAL STUDY

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039401
Enrollment
60
Registered
2022-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 40-70 yrs. 2.Chronicity: 6 months to 10 yrs. 3. Gender :Both. 4. Socio-economic status: All 5.Degenerative changes in X- ray of knee joint (Grade 1, 2, 3) 6.Subjects fit for Basti Karma and Brimhana Snehapana

Exclusion criteria

Exclusion criteria: 1.Subjects with Diabetes Mellitus 2.Subjects diagnosed with Rheumatoid Arthritis. 3.Subjects with infective arthritis. 4.Subjects unfit for Basti karma, Brimhana Snehapana. 5.Grade 4 in X ray finding of Knee Joint. 6.Subjects having BMI more than 30 7.Traumatic cases like fractures of Knee Joint.

Design outcomes

Primary

MeasureTime frame
1.Reduction in Pain 2.Improvement in Range of Motion Timepoint: (DAY-0)(DAY-13)(DAY-27)(DAY-34)(DAY-64)

Secondary

MeasureTime frame
Reduction in symptoms like swelling, tenderness, crepitation, improvement in range of motion. Timepoint: (DAY-0)(DAY-13)(DAY-27) (DAY-34)(DAY-64)

Countries

India

Contacts

Public ContactDr Anandaraman P V

All India Institute of Ayurveda, New Delhi 110076

santoshbhatted@rediffmail.com9414048459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026